AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases

Xiaoliang Wu,Wenjuan Ma,Qianghua Zhou,Haijuan Yan,Zuan-Fu Lim,Mayan Huang,Chuangzhong Deng,Xingsu Yu,Huifang Su,Satoshi Komo,Haixia Yang,Xinke Zhang,Sijin Wen,Zhenfeng Zhang,Patrick C. Ma

AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases

2017

Xiaoliang Wu
Wenjuan Ma
Qianghua Zhou
Haijuan Yan
Zuan-Fu Lim
Mayan Huang
Chuangzhong Deng
Xingsu Yu
Huifang Su
Satoshi Komo
Haixia Yang
Xinke Zhang
Sijin Wen
Zhenfeng Zhang
Patrick C. Ma

Purpose Patients with non-small cell lung cancer (NSCLC) brain metastases (BM) have poor clinical outcomes. We sought to determine if AXL–GAS6 expression can be used as independent prognostic biomarkers for NSCLC BM.

Keywords:

Cell
Brain metastasis
Pathology
GAS6
Biomarker (medicine)
Lung cancer
Biology
Oncology
Hematology
T-stage
Risk factor
Internal medicine
Univariate analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations